LSX Congress USA brings together biotech leaders, pharma BD teams and active investors from across North America and beyond, creating a focused environment for strategic conversations, investment discussions and partnership development.
For life science companies, the Congress offers a valuable opportunity to build visibility with the US and global market, connect with investors, and engage with pharma BD teams exploring new innovation, licensing and partnership opportunities.
This year’s speaker faculty includes senior leaders from organisations such as Boehringer Ingelheim, Eli Lilly, AbbVie, Blackstone Life Sciences, Johnson & Johnson, GSK, Ipsen, Servier, Astellas Pharma, BNP Paribas Asset Management, Panacea Capital and Vida Ventures.
SwedenBIO members receive a discount. Contact us on info@swedenbio.se if you don’t know where to find our discount code.
More info and Register here
